Skip to main content
TipRanks
Go Ultimate75% OFF

Oceania Healthcare (OCA) AI Stock Analysis

1 Followers
NZ:OCA

Oceania Healthcare

(NZX:OCA)

Select Model
Rating:50Neutral
Price Target:NZD 0.59â–²(0.00% Upside)
Action:initiatedcoverage
Date:10/05/26

The score is held back primarily by the sharp recent earnings and revenue deterioration and a weak technical trend (price below key moving averages with negative MACD). These are partially offset by strong recent operating and free cash flow and an improving leverage profile, but valuation metrics are a major drag due to the extremely high P/E and no provided dividend yield.

Positive Factors
Strong Cash GenerationConsistently positive free cash flow, including approximately $140M in 2026, gives Oceania capacity to fund operations, maintain communities, and pursue development internally. This supports financial flexibility and provides a durable buffer against volatility in reported earnings.
Negative Factors
Revenue ContractionThe latest revenue contraction signals a meaningful weakening in top-line performance rather than steady expansion. If sustained, lower revenue would constrain operating leverage, reduce funding available for portfolio investment, and make it harder for Oceania to absorb fixed care and property costs.

Oceania Healthcare (OCA) vs. SPDR S&P 500 ETF (SPY)

-30%-20%-10%0%10%20%NZ:OCA-28.92%SPY+4.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
NZD 358.49M
Dividend Yield
―
Average Volume (3M)
541.22K
Price to Earnings (P/E)
-63.4
Beta (1Y)
0.95
Revenue Growth
1.25%
EPS Growth
-117.68%
Country
NZ
Employees
2,246
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Oceania Healthcare Business Overview & Revenue Model

Company Description

Oceania Healthcare Limited, headquartered in Auckland, New Zealand, owns and operates a network of retirement villages and aged care facilities across the country. The company's business activities are categorized into three primary segments: Care Op...

How the Company Makes Money

Oceania’s revenue is primarily generated from (1) its retirement village operations and (2) its aged care operations. In retirement villages, it earns income from selling occupation rights to independent living units (commonly structured in New Zeala...

Oceania Healthcare Financial Statement Overview

Summary

Mixed fundamentals: cash flow is strong (2026 operating cash flow ~$158M and free cash flow ~$140M) and leverage has improved (debt-to-equity down to ~0.45 in 2026). However, the latest year shows clear deterioration in operating results with revenue down ~18.6% YoY and profitability near break-even with very low margins, materially weighing on the score.

Income Statement

42Neutral

Balance Sheet

63Positive

Cash Flow

74Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue330.73M267.14M260.57M265.46M247.18M231.14M
Gross Profit2.48M45.03M260.57M265.46M46.51M38.61M
EBITDA-5.88M4.00M68.05M63.35M53.36M89.01M
Net Income-11.67M119.00K30.41M31.47M15.45M61.13M
Balance Sheet
Total Assets3.13B3.08B2.94B2.78B2.54B2.20B
Cash, Cash Equivalents and Short-Term Investments8.23M16.59M7.59M7.49M7.44M9.74M
Total Debt0526.81M638.31M651.72M558.39M390.03M
Total Liabilities1.95B1.90B1.84B1.76B1.58B1.25B
Stockholders Equity1.18B1.18B1.10B1.03B962.26M948.84M
Cash Flow
Free Cash Flow156.32M140.01M70.47M33.36M15.05M49.24M
Operating Cash Flow177.79M157.80M110.28M85.37M70.21M105.53M
Investing Cash Flow-12.28M-33.42M-100.31M-161.25M-219.60M-218.82M
Financing Cash Flow-161.92M-115.38M-9.86M75.92M147.09M43.13M

Oceania Healthcare Technical Analysis

Technical Analysis SentimentNegative
Last Price0.59

Price Trends

50DMA0.68Negative
100DMA0.73Negative
200DMA0.74Negative

Market Momentum

MACD-0.02Positive
RSI28.54Positive
STOCH6.06Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NZ:OCA, the sentiment is Negative. The current price of 0.59 is below the 20-day moving average (MA) of 0.64, below the 50-day MA of 0.68, and below the 200-day MA of 0.74, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 28.54 is Positive, neither overbought nor oversold. The STOCH value of 6.06 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NZ:OCA.

Oceania Healthcare Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

NZ:OCA against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
NZ:TAHNZ:TAH70OutperformNZD 37.83M11.70―4.15%21.56%18.96%
NZ:SUMNZ:SUM67NeutralNZD 1.46B4.598.89%2.94%14.09%-18.30%
NZ:PHLNZ:PHL63NeutralNZD 33.62M0.03――15.19%1154.17%
NZ:RADNZ:RAD56NeutralNZD 113.39M10.18―6.03%9.76%-1.75%
NZ:RYMNZ:RYM56NeutralNZD 1.91B-11.12-4.17%―11.86%72.99%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
NZ:OCANZ:OCA50NeutralNZD 449.02M-63.44-0.57%―1.25%-117.68%

* Healthcare Sector Average

Performance Comparison

-40%-20%0%20%40%NZ:OCANZ:RYMNZ:SUMNZ:PHLNZ:TAHNZ:RADDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
NZ:OCA and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
NZ:OCAOceania Healthcare Ltd.0.59-0.22-27.16%
NZ:RYMRyman Healthcare 1.83-1.06-36.66%
NZ:SUMSummerset Group Holdings Limited5.79-6.60-53.27%
NZ:PHLPromisia Healthcare Limited0.620.0611.71%
NZ:TAHThird Age Health Services Limited3.86-1.74-31.12%
NZ:RADRadius Residential Care Ltd0.400.024.99%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 05, 2026